JPS60208980A - チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤 - Google Patents

チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤

Info

Publication number
JPS60208980A
JPS60208980A JP60041584A JP4158485A JPS60208980A JP S60208980 A JPS60208980 A JP S60208980A JP 60041584 A JP60041584 A JP 60041584A JP 4158485 A JP4158485 A JP 4158485A JP S60208980 A JPS60208980 A JP S60208980A
Authority
JP
Japan
Prior art keywords
pyridyl
compound
thiazolidinedione
methyl
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60041584A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0570633B2 (enFirst
Inventor
Kanji Meguro
寛司 目黒
Takeshi Fujita
剛 藤田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of JPS60208980A publication Critical patent/JPS60208980A/ja
Publication of JPH0570633B2 publication Critical patent/JPH0570633B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60041584A 1984-03-21 1985-03-01 チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤 Granted JPS60208980A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1984/000117 WO1985004170A1 (fr) 1984-03-21 1984-03-21 Derives de thiazolidinedione, leur procede de preparation et compositions medicinales les contenant
WO84/00117 1984-03-21
WO84/00445 1984-09-14

Publications (2)

Publication Number Publication Date
JPS60208980A true JPS60208980A (ja) 1985-10-21
JPH0570633B2 JPH0570633B2 (enFirst) 1993-10-05

Family

ID=13818276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60041584A Granted JPS60208980A (ja) 1984-03-21 1985-03-01 チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤

Country Status (2)

Country Link
JP (1) JPS60208980A (enFirst)
WO (2) WO1985004170A1 (enFirst)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508740A1 (en) 1991-04-11 1992-10-14 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, their production and their use
JP2009530283A (ja) * 2006-03-16 2009-08-27 メタボリック ソリューションズ ディベロップメント カンパニー 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体
JP2009530293A (ja) * 2006-03-16 2009-08-27 メタボリック ソリューションズ ディベロップメント カンパニー チアゾリジンジオン類似体およびグルココルチコイドアゴニストの併用療法
JP2009530286A (ja) * 2006-03-16 2009-08-27 メタボリック ソリューションズ ディベロップメント カンパニー 高血圧症を処置するためならびに脂質を下げるためのチアゾリジンジオン類似体

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891216A (en) * 1987-04-14 1990-01-02 Alcide Corporation Disinfecting compositions and methods therefor
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010105048A1 (en) * 2009-03-12 2010-09-16 Metabolic Solutions Development Company Thiazolidinedione analogues
DK2513070T3 (en) 2009-12-15 2018-01-22 Cirius Therapeutics Inc PPAR-sparing thiazolidinedione salts for the treatment of metabolic disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508740A1 (en) 1991-04-11 1992-10-14 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, their production and their use
JP2009530283A (ja) * 2006-03-16 2009-08-27 メタボリック ソリューションズ ディベロップメント カンパニー 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体
JP2009530293A (ja) * 2006-03-16 2009-08-27 メタボリック ソリューションズ ディベロップメント カンパニー チアゾリジンジオン類似体およびグルココルチコイドアゴニストの併用療法
JP2009530286A (ja) * 2006-03-16 2009-08-27 メタボリック ソリューションズ ディベロップメント カンパニー 高血圧症を処置するためならびに脂質を下げるためのチアゾリジンジオン類似体
JP2012251001A (ja) * 2006-03-16 2012-12-20 Metabolic Solutions Development Co Llc 高血圧症を処置するためならびに脂質を下げるためのチアゾリジンジオン類似体
JP2013100371A (ja) * 2006-03-16 2013-05-23 Metabolic Solutions Development Co Llc 代謝性炎症によって媒介される疾患を処置するためのチアゾリジンジオン類似体

Also Published As

Publication number Publication date
WO1985004171A1 (fr) 1985-09-26
JPH0570633B2 (enFirst) 1993-10-05
WO1985004170A1 (fr) 1985-09-26

Similar Documents

Publication Publication Date Title
US4582839A (en) 2,4-thiazolidinediones
US5441971A (en) Thiazolidinedione derivatives, production and use thereof
US4725610A (en) Thiazolidinedione derivatives, their production and use
EP0579733B1 (en) Thiazolidinedione derivatives, production and use thereof
US6100403A (en) Production of benzaldehyde compounds
HU195210B (en) Process for producing pyridine derivatives and pharmaceutical preparations comprising these compounds as active substance
JPH0283384A (ja) 新規化合物、その製法及びそれを含む医薬組成物
JPH0782269A (ja) チアゾリジンジオン誘導体、その製造法およびそれを含んでなる医薬組成物
JPS634537B2 (enFirst)
EP0295603A1 (en) Benzimidazol derivatives and therapeutic agent for ulcer comprising the same
JPS60208980A (ja) チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤
EP0508740A1 (en) Thiazolidinedione derivatives, their production and their use
CN1056369C (zh) 哒嗪酮衍生物或其盐和制备方法
WO1986002073A1 (fr) Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant
JPS6216469A (ja) ２−置換シクロヘプトイミダゾ−ル誘導体、抗潰瘍剤及びその製造方法
JP3466273B2 (ja) テトラゾール誘導体、その製造法およびそれを含んでなる医薬
JPS6136284A (ja) チアゾリジン誘導体およびその製造方法
WO1990011278A1 (fr) Composes de thiazole et leurs applications
JPS61282369A (ja) オキサゾ−ル誘導体の製造法
JPS62111980A (ja) １ｈ−ベンズイミダゾ−ル誘導体
JPH0125742B2 (enFirst)
JPH0430957B2 (enFirst)
JPS61145182A (ja) イミダゾピリジン誘導体
JPH03157376A (ja) チアゾール系化合物およびその用途
JPH0249781A (ja) ピリジニウム誘導体

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term